Article 1 to 10 out of 53 concerning Generex Biotechnology Corporation
Generex Subsidiary Antigen Express Receives Patent in China for Its Ii-Key Peptide Vaccine Technology(03 Mar 2010) Company in Active Discussions with Several Large Pharmaceutical Companies for Potential Joint Venture/Licensing Partnerships for Its Cancer Vaccine Technology Platform Generex Biotechnology Corporation announced that it has received notice of issuance of a patent on its Ii-Key peptide technology in China. This expands a solid intellectual property estate that includes both broad claims covering its technology as ...
Generex inks deal with Sanofi-Aventis for insulin supply(10 Dec 2009) Generex Biotechnology Corporation announced that it has signed a long-term agreement with Sanofi-Aventis Deutschland GmbH for the manufacture and supply of recombinant human insulin crystals for commercial and clinical trial use in Generex’s ...
Generex announces USFDA approval of use of company's buccal insulin product(14 Sep 2009) Generex Biotechnology Corporation announced that the U.S. Food and Drug Administration (FDA) has granted approval for the treatment use of Generex Oral-lyn™ under the FDA’s Treatment Investigational New Drug (IND) program.Under a structured ...
Generex Announces Agreement with the Immune Tolerance Network(23 Apr 2009) Generex Biotechnology Corporation announced that Antigen Express, Inc., the Company’s wholly-owned immunotherapeutics subsidiary, and the Immune Tolerance Network have signed an agreement aimed at implementing a better diagnostic test for Type I ...
Generex Awarded New Patent in Morocco(14 Apr 2009) Generex Biotechnology Corporation announced that it has received a new patent in Morocco. The Moroccan Industrial and Commercial Property Office granted the Company its first Moroccan patent, titled "Orally Absorbed Pharmaceutical Formulation and ...
Generex Awarded New Patent in Europe(19 Dec 2008) Company Expands Patent Portfolio in Several European Countries Generex Biotechnology Corporation announced that it has received a new European patent. The European Patent Office granted the Company its sixth European patent titled, "Micellar Pharmaceutical Compositions for Buccal and Pulmonary Application." ...
Generex Awarded New Pain Relief Patents(21 Nov 2008) Company Expands Patent Portfolio in Mexico and New Zealand Generex Biotechnology Corporation announced that it has received two new patents, one in Mexico (issued by the Mexican Institute of Industrial Property), the other in New Zealand (issued by the Intellectual Property Office of New Zealand).The ...
Generex Biotechnology Awarded New Drug Delivery Patent(29 Oct 2008) Company Expands Australian Patent Portfolio Generex Biotechnology Corporation announced that it has received a new patent in Australia. The Australian Patent Office has granted the Company a patent titled Micellar Pharmaceutical Compositions for Buccal and Pulmonary Application. The patent ...
Top
